Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation -: EFRAM Study

被引:206
作者
Garcia-Aymerich, J
Monsó, E
Marrades, RM
Escarrabill, J
Félez, MA
Sunyer, J
Antó, JM
Alonso, J
Barreiro, E
Farrero, E
Redondo, MJ
Soler, N
Torres, A
Bonet, G
Izquierdo, J
Morera, J
机构
[1] Inst Municipal Invest Med, Resp & Environm Hlth Res Unit, E-08003 Barcelona, Spain
[2] Hosp Badalona Germans Trias & Pujol, Dept Pneumol, Badalona, Spain
[3] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain
[4] Ciutat Sanitaria & Univ Bellvitge, Dept Pneumol, Lhospitalet DeLlobregat, Spain
[5] Hosp Mare Deu Esperanca, Dept Pneumol, Barcelona, Spain
[6] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
关键词
COPD; exacerbation; hospitalization; risk factors; case-control;
D O I
10.1164/ajrccm.164.6.2006012
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Although exacerbation of chronic obstructive pulmonary disease (COPD) is important in terms of health and costs, there is little information about which are the risk factors. We estimated the association between modifiable and nonmodifiable potential risk factors of exacerbation and the admission for a COPD exacerbation, using a case-control approach. Cases were recruited among admissions for COPD exacerbation during 1 yr in four tertiary hospitals of the Barcelona area. Control subjects were recruited from hospital's register of discharges, having coincided with the referent case in a previous COPD admission but being clinically stable when the referent case was hospitalized. All patients completed a questionnaire and performed spirometry, blood gases, and physical examination. Information about potential risk factors was collected, including variables related to clinical status, characteristics of medical care, medical prescriptions, adherence to medication, lifestyle, quality of life, and social support. A total of 86 cases and 86 control subjects were included, mean age 69 yr, mean FEV1 39% of predicted. Multivariate logistic regression showed the following risk (or protective) factors of COPD hospitalization: three or more COPD admissions in the previous year (odds ratio [OR] 6.21, p = 0.008); FEV1 (OR 0.96 per percentual unit, p < 0.0005); underprescription of long-term oxygen therapy (LTOT) (OR 22.64, p = 0.007); and current smoking (OR 0.30, p = 0.022). Among a wide range of potential risk factors we have found that only previous admissions, lower FEV1, and underprescription of LTOT are independently associated with a higher risk of admission for a COPD exacerbation.
引用
收藏
页码:1002 / 1007
页数:6
相关论文
共 31 条
[1]
Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project [J].
Anderson, HR ;
Spix, C ;
Medina, S ;
Schouten, JP ;
Castellsague, J ;
Rossi, G ;
Zmirou, D ;
Touloumi, G ;
Wojtyniak, B ;
Ponka, A ;
Bacharova, L ;
Schwartz, J ;
Katsouyanni, K .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (05) :1064-1071
[2]
[Anonymous], 1980, Ann Intern Med, V93, P391
[3]
ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[4]
Smoking, lung function, and mortality [J].
Anthonisen, NR .
THORAX, 2000, 55 (09) :729-730
[5]
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[6]
BURROWS B, 1991, EUR RESPIR REV, V1, P340
[8]
CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77
[9]
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease [J].
Collet, JP ;
Shapiro, S ;
Ernst, P ;
Renzi, P ;
Ducruet, T ;
Robinson, A ;
Gauthier, G ;
Beaupre, A ;
Gregoire, P ;
Jacquemin, P ;
Plante, F ;
Lachance, Y ;
Provost, G ;
Hernandez, P ;
JeanFrancois, R ;
Charbonneau ;
Inhaber, N ;
Braidy, J ;
Jeanneret, A ;
Bolduc, P ;
Leblanc, PP ;
Olivenstein, R ;
Mannix, S ;
Chrysler, B ;
Wolkove, N ;
Kreisman, H ;
Frank ;
Fox, J ;
Colman, N ;
Gruber, J ;
Zidulka ;
Gursahaney, A ;
Matouk ;
Eidelman, D ;
Julien, M ;
Malo, J ;
Dandurand, R ;
Skamene, E ;
Suissa, S ;
Choi, S ;
Martin, J ;
Dankoff, G ;
Enjalbert, M ;
Lauener, PA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1719-1724
[10]
Outcomes following acute exacerbation of severe chronic obstructive lung disease [J].
Connors, AF ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Desbiens, N ;
Fulkerson, WJ ;
Kussin, P ;
Bellamy, P ;
Goldman, L ;
Knaus, WA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :959-967